Home
Catalogue search
Refine your search:
Keyword:
Humans (3)
Aged (2)
Cardiovascular Diseases / etiology (2)
Cholesterol / blood (2)
Combination (2)
Diabetes Mellitus (2)
Double-Blind Method (2)
Drug Therapy (2)
Fatty Acids (2)
Female (2)
more
Creator / Publisher:
Li, H. (4)
Liu, S. (4)
Wang, C. (4)
Wang, H. (4)
Wang, Y. (4)
Ahmed, I. (3)
Chen, J. (3)
Chen, M. (3)
Chen, Y. (3)
Choi, Y. (3)
more
Year:
2021 (1)
2017 (1)
2012 (2)
Medium:
Online (4)
Type
BLLDB-Access
Search in the Catalogues and Directories
All fields
Title
Creator / Publisher
Keyword
Year
AND
OR
AND NOT
All fields
Title
Creator / Publisher
Keyword
Year
AND
OR
AND NOT
All fields
Title
Creator / Publisher
Keyword
Year
AND
OR
AND NOT
All fields
Title
Creator / Publisher
Keyword
Year
AND
OR
AND NOT
All fields
Title
Creator / Publisher
Keyword
Year
Sort by
creator [A → Z]
'
creator [Z → A]
'
publishing year ↑ (asc)
'
publishing year ↓ (desc)
'
title [A → Z]
'
title [Z → A]
'
Simple Search
Hits 1 – 4 of 4
1
The trans-ancestral genomic architecture of glycemic traits.
Chen, J.
;
Spracklen, C.N.
;
Marenne, G.
...
In: Nature genetics, vol. 53, no. 6, pp. 840-860 (2021)
BASE
Show details
2
Search for dark matter produced in association with heavy-flavor quark pairs in proton-proton collisions at [Formula: see text]
Sirunyan, A. M.
;
Tumasyan, A.
;
Adam, W.
. - : Springer Berlin Heidelberg, 2017
BASE
Show details
3
Basal insulin and cardiovascular and other outcomes in dysglycemia.
Gerstein, H.C.
;
Bosch, J.
;
Dagenais, G.R.
...
In: New England Journal of Medicine, vol. 367, no. 4, pp. 319-328 (2012)
BASE
Show details
4
n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.
Bosch, J.
;
Gerstein, H.C.
;
Dagenais, G.R.
;
Díaz, R.
;
Dyal, L.
;
Jung, H.
;
Maggiono, A.P.
;
Probstfield, J.
;
Ramachandran, A.
;
Riddle, M.C.
;
Rydén, L.E.
;
Yusuf, S.
In: New England Journal of Medicine, vol. 367, no. 4, pp. 309-318 (2012)
Abstract:
BACKGROUND: The use of n-3 fatty acids may prevent cardiovascular events in patients with recent myocardial infarction or heart failure. Their effects in patients with (or at risk for) type 2 diabetes mellitus are unknown. METHODS: In this double-blind study with a 2-by-2 factorial design, we randomly assigned 12,536 patients who were at high risk for cardiovascular events and had impaired fasting glucose, impaired glucose tolerance, or diabetes to receive a 1-g capsule containing at least 900 mg (90% or more) of ethyl esters of n-3 fatty acids or placebo daily and to receive either insulin glargine or standard care. The primary outcome was death from cardiovascular causes. The results of the comparison between n-3 fatty acids and placebo are reported here. RESULTS: During a median follow up of 6.2 years, the incidence of the primary outcome was not significantly decreased among patients receiving n-3 fatty acids, as compared with those receiving placebo (574 patients [9.1%] vs. 581 patients [9.3%]; hazard ratio, 0.98; 95% confidence interval [CI], 0.87 to 1.10; P=0.72). The use of n-3 fatty acids also had no significant effect on the rates of major vascular events (1034 patients [16.5%] vs. 1017 patients [16.3%]; hazard ratio, 1.01; 95% CI, 0.93 to 1.10; P=0.81), death from any cause (951 [15.1%] vs. 964 [15.4%]; hazard ratio, 0.98; 95% CI, 0.89 to 1.07; P=0.63), or death from arrhythmia (288 [4.6%] vs. 259 [4.1%]; hazard ratio, 1.10; 95% CI, 0.93 to 1.30; P=0.26). Triglyceride levels were reduced by 14.5 mg per deciliter (0.16 mmol per liter) more among patients receiving n-3 fatty acids than among those receiving placebo (P<0.001), without a significant effect on other lipids. Adverse effects were similar in the two groups. CONCLUSIONS: Daily supplementation with 1 g of n-3 fatty acids did not reduce the rate of cardiovascular events in patients at high risk for cardiovascular events. (Funded by Sanofi; ORIGIN ClinicalTrials.gov number, NCT00069784.).
Keyword:
Aged
;
Cardiovascular Diseases/etiology
;
Cardiovascular Diseases/mortality
;
Cholesterol/blood
;
Combination
;
Diabetes Mellitus
;
Double-Blind Method
;
Drug Therapy
;
Fatty Acids
;
Female
;
Follow-Up Studies
;
Glucose Intolerance/complications
;
Glucose Intolerance/drug therapy
;
Humans
;
Hypoglycemic Agents/therapeutic use
;
Incidence
;
Insulin
;
Intention to Treat Analysis
;
Long-Acting/therapeutic use
;
Male
;
Middle Aged
;
Omega-3/therapeutic use
;
Proportional Hazards Models
;
Treatment Failure
;
Triglycerides/blood
;
Type 2/complications
;
Type 2/drug therapy
URL:
https://doi.org/10.1056/NEJMoa1203859
https://serval.unil.ch/notice/serval:BIB_83A3987D7CC1
BASE
Hide details
Mobile view
All
Catalogues
UB Frankfurt Linguistik
0
IDS Mannheim
0
OLC Linguistik
0
UB Frankfurt Retrokatalog
0
DNB Subject Category Language
0
Institut für Empirische Sprachwissenschaft
0
Leibniz-Centre General Linguistics (ZAS)
0
Bibliographies
BLLDB
0
BDSL
0
IDS Bibliografie zur deutschen Grammatik
0
IDS Bibliografie zur Gesprächsforschung
0
IDS Konnektoren im Deutschen
0
IDS Präpositionen im Deutschen
0
IDS OBELEX meta
0
MPI-SHH Linguistics Collection
0
MPI for Psycholinguistics
0
Linked Open Data catalogues
Annohub
0
Online resources
Link directory
0
Journal directory
0
Database directory
0
Dictionary directory
0
Open access documents
BASE
4
Linguistik-Repository
0
IDS Publikationsserver
0
Online dissertations
0
Language Description Heritage
0
© 2013 - 2024 Lin|gu|is|tik
|
Imprint
|
Privacy Policy
|
Datenschutzeinstellungen ändern